Tag: Zeteo Biomedical LLC
Launch: With AriesMR Active Dry Powder Inhaler, Zeteo Biomedical Expands into Pulmonary Drug Delivery
Product Launches: -- Zeteo Biomedical LLC today announced the expansion of its ZTECH-P™ powder drug-delivery platform into pulmonary delivery with the introduction of AriesMR™, a reloadable active dry powder inhaler designed for controlled pulmonary administration of pharmaceutical powders without reliance on patient-generated inspiratory energy for powder aerosolization or the use of CFC/HFA propellants.
Launch: Zeteo Biomedical Introduces CygnusMR and CygnusSDX Delivery Devices for Nasal Administration of Biologics
Product Launches: -- Zeteo Biomedical LLC today announced the launch of its ZTech-P CygnusMR™ and CygnusSDX™ delivery devices, designed for precise, metered-unit dosing of dry powder drugs and biologics via systemic nasal and nose-to-brain administration. These innovative needle-free delivery systems provide pharmaceutical and biotech companies with advanced solutions to accelerate the development, clinical evaluation, and commercial deployment of dry powder nasal combination products for a broad range of therapeutic applications.
Launch: Zeteo Biomedical LLC Introduces OrionMRQ Nasal Delivery Device for Drugs and Vaccines
Product Launches: -- Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo's latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.
